These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33306354)

  • 1. Stopping Membrane-Enveloped Viruses with Nanotechnology Strategies: Toward Antiviral Drug Development and Pandemic Preparedness.
    Yoon BK; Jeon WY; Sut TN; Cho NJ; Jackman JA
    ACS Nano; 2021 Jan; 15(1):125-148. PubMed ID: 33306354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral peptide engineering for targeting membrane-enveloped viruses: Recent progress and future directions.
    Jackman JA
    Biochim Biophys Acta Biomembr; 2022 Feb; 1864(2):183821. PubMed ID: 34808121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biophysical Measurement Strategies for Antiviral Drug Development: Recent Progress in Virus-Mimetic Platforms Down to the Single Particle Level.
    Park S; Tae H; Cho NJ
    Acc Chem Res; 2021 Aug; 54(16):3204-3214. PubMed ID: 34346210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Broad-Spectrum Antiviral Entry Inhibition by Interfacially Active Peptides.
    Hoffmann AR; Guha S; Wu E; Ghimire J; Wang Y; He J; Garry RF; Wimley WC
    J Virol; 2020 Nov; 94(23):. PubMed ID: 32907984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical design principles of next-generation antiviral surface coatings.
    Wang N; Ferhan AR; Yoon BK; Jackman JA; Cho NJ; Majima T
    Chem Soc Rev; 2021 Sep; 50(17):9741-9765. PubMed ID: 34259262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of an Aquatic Rhabdovirus Demonstrates Promise of a Broad-Spectrum Antiviral for Use in Aquaculture.
    Balmer BF; Powers RL; Zhang TH; Lee J; Vigant F; Lee B; Jung ME; Purcell MK; Snekvik K; Aguilar HC
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27903801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral Envelope Membrane: A Special Entry Pathway and a Promising Drug Target.
    Palombi N; Brai A; Gerace M; Di Maria S; Orofino F; Corelli F
    Curr Med Chem; 2021 Oct; 28(34):6957-6976. PubMed ID: 33602071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanomedicine for Infectious Disease Applications: Innovation towards Broad-Spectrum Treatment of Viral Infections.
    Jackman JA; Lee J; Cho NJ
    Small; 2016 Mar; 12(9):1133-9. PubMed ID: 26551316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral nanopharmaceuticals: Engineered surface interactions and virus-selective activity.
    Kolanthai E; Neal CJ; Kumar U; Fu Y; Seal S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Sep; 14(5):e1823. PubMed ID: 35697665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fusion Protein Targeted Antiviral Peptides: Fragment-Based Drug Design (FBDD) Guided Rational Design of Dipeptides Against SARS-CoV-2.
    Manna S; Chowdhury T; Baindara P; Mandal SM
    Curr Protein Pept Sci; 2020; 21(10):938-947. PubMed ID: 32901582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can nanotechnology help in the fight against COVID-19?
    Palestino G; García-Silva I; González-Ortega O; Rosales-Mendoza S
    Expert Rev Anti Infect Ther; 2020 Sep; 18(9):849-864. PubMed ID: 32574081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Broad-Spectrum Antiviral Peptide Blocks Infection of Viruses by Binding to Phosphatidylserine in the Viral Envelope.
    Luteijn RD; Praest P; Thiele F; Sadasivam SM; Singethan K; Drijfhout JW; Bach C; de Boer SM; Lebbink RJ; Tao S; Helfer M; Bach NC; Protzer U; Costa AI; Killian JA; Drexler I; Wiertz EJHJ
    Cells; 2020 Aug; 9(9):. PubMed ID: 32872420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanotechnology advances in pathogen- and host-targeted antiviral delivery: multipronged therapeutic intervention for pandemic control.
    Yang KC; Lin JC; Tsai HH; Hsu CY; Shih V; Hu CJ
    Drug Deliv Transl Res; 2021 Aug; 11(4):1420-1437. PubMed ID: 33748879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of the antiviral activity of cationic antimicrobial peptides.
    Urmi UL; Vijay AK; Kuppusamy R; Islam S; Willcox MDP
    Peptides; 2023 Aug; 166():171024. PubMed ID: 37172781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral Activity of Graphene-Silver Nanocomposites against Non-Enveloped and Enveloped Viruses.
    Chen YN; Hsueh YH; Hsieh CT; Tzou DY; Chang PL
    Int J Environ Res Public Health; 2016 Apr; 13(4):430. PubMed ID: 27104546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broad-spectrum antivirals of protoporphyrins inhibit the entry of highly pathogenic emerging viruses.
    Lu S; Pan X; Chen D; Xie X; Wu Y; Shang W; Jiang X; Sun Y; Fan S; He J
    Bioorg Chem; 2021 Feb; 107():104619. PubMed ID: 33450541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparing for the next viral threat with broad-spectrum antivirals.
    Karim M; Lo CW; Einav S
    J Clin Invest; 2023 Jun; 133(11):. PubMed ID: 37259914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced Nanomaterials for Preparedness Against (Re-)Emerging Viral Diseases.
    Kim E; Lim EK; Park G; Park C; Lim JW; Lee H; Na W; Yeom M; Kim J; Song D; Haam S
    Adv Mater; 2021 Nov; 33(47):e2005927. PubMed ID: 33586180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Progress on Biomaterials Fighting against Viruses.
    Li S; Guo X; Gao R; Sun M; Xu L; Xu C; Kuang H
    Adv Mater; 2021 Apr; 33(14):e2005424. PubMed ID: 33644954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Enveloped Virus Surrogate Phi6 Infection Using Yeast-Derived Vacuoles.
    Choi W; Kim YH; Min J
    Microbiol Spectr; 2023 Feb; 11(1):e0266122. PubMed ID: 36688634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.